Locations
San Francisco, CA, USA
industry
Biotechnology · DeepTech · Health
Size
1 - 10 employees
Stage
Other
founded in
2020
Sardona Therapeutics is pioneering a drug discovery platform focused on developing small molecule drugs that target RNA-binding proteins (RBPs) to treat cancer and other diseases. Their innovative approach links RBPs to therapy-resistant cancers, aiming to create precision medicine solutions that address high unmet needs in oncology. With a unique RBP Topography Map and proprietary screening assays, Sardona is positioned to advance a new class of cancer therapies, potentially expanding applications beyond oncology. The company is addressing a significant market need, as over 30 million people in the U.S. are projected to have therapy-resistant cancers by 2030, making their work critical in the fight against aggressive cancers.
Something looks off?